Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2020-03-05 2020-03-05
Drug Identification Number 02257734 02257734
Brand name ACT METFORMIN ACT METFORMIN
Common or Proper name METFORMIN 850MG FC TAB METFORMIN 850MG FC TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE
Strength(s) 850MG 850MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 500
ATC code A10BA A10BA
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-15 2020-01-15
Estimated end date 2020-05-31 2020-05-31
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments